Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
Study Director
Michael Hoelscher
Start Date
10 / 2019
Trial Phase
Phase I
Trial Status
study in development
Current Enrollment
Target Enrollment
77
Overview
Registry Link
Developer Associations
University of Munich
EDCTP
Compound Associations
BTZ-043